Exelixis Inc. (NASDAQ: EXEL) Rating Reiterated at Leerink Swann

Leerink Swann analysts reiterated its Outperform rating on Exelixis Inc. (NASDAQ: EXEL) in a note to investors, making it one of the more closely watched stocks on Wall Street. With a rating of Outperform on the shares, Exelixis Inc. has a 52-week high of $14.28. The one-year price target of $12.67 is less than the opening price of $13.80, resulting a fair amount of other analysts to issue statements on the company in recent days. Stock prices sometimes get a bounce to the upside when analysts reiterate coverage.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Shares of Exelixis Inc. (NASDAQ: EXEL) opened at $13.80 yesterday and traded in a range between, $13.70 and $14.28, and last traded at $14.16, which represents an increase of $0.52 compared to the previous closing price.

Exelixis Inc. (NASDAQ: EXEL) now has a market cap of 3.26B.

6,108,102 shares crossed the trading desk yesterday, 62 percent above the norm, out of a total float 212,111,000. Excessive volume accumulation by institutional investors may be on the horizon as the combination of substantial increases in trading volume and price appreciation can be determining components.

As with all possible breakouts, investors watch for volume to be at least 40%-50% greater than normal on the breakout to indicate that fund managers and other professional investors are jumping in.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain substantial teams of analysts researching thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.

Traders can make the best trades when they follow the activity of professional investors.

With that in mind, Exelixis Inc. (NASDAQ: EXEL) now has a 50-day MA of $11.45 and 200-day MA of $7.38. It has traded in a 52-week range between $3.55 – 14.28 and today’s last price is 0.01% lower than the 52 week high of $14.28.

Earnings growth is a crucial factor to consider when investing in stocks and investors watch for companies that have raised their earnings by at least 25% over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.